| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.22 | 5e-10 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |